Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Checking how cells grow

24.04.2003


New research dismisses a widely held assumption about how cells grow



Research published today in Journal of Biology challenges an assumption about cell growth that underpins modern cellular biology. Ian Conlon and Martin Raff, of University College London, show that mammalian cells do not regulate their size in the way scientists have assumed they do since the 1970s.
Conlon and Raff conducted a series of experiments, using Schwann cells from the sciatic nerve of rats, to establish how mammalian cells control their size and ‘decide’ when to divide. This processes of cell size, growth and division has been widely studied in yeast for thirty years, and many aspects are the same in the two types of cell. Both yeast and mammalian cells are known to be able to maintain a constant average size as they grow and divide. It has therefore been assumed that the ‘checkpoints’ yeast cells use to ensure that they divide when they reach the correct size are mirrored by checkpoints in mammalian cells, but that assumption had not been tested experimentally - until now.

Using precise measurements, Conlon and Raff found key differences in the ways yeast and mammalian cells grow. Yeast cells grow exponentially, doubling in size over a fixed time period, but mammalian cells grow in a linear way, getting larger by the same amount each day; this means that the rate at which mammalian cells grow is the same regardless of the cell’s size, whereas in yeast big cells grow faster than small ones.



Previous research had shown that when moved to a nutrient-rich environment, yeast cells adjust quickly - within one cycle of growth and division. The average size of the cells increases when there are more nutrients available – so, yeast uses cell-size checkpoints to determine how large the cell should be before it divides.

It had been assumed that mammalian cells also use cell-size checkpoints. But Conlon and Raff found that when mammalian cells were moved to a nutrient-rich environment, it took approximately six divisions before cells grew to the average size they expected. This led them to conclude that mammalian cells do not use checkpoints based on their size to determine when to divide. Instead, Conlon and Raff suggest that mammalian cells ‘talk’ to each other, using extracellular signalling, to determine how large they should grow and when they should divide. “Animal cells hardly do anything without signals from other cells” says Raff.

The new research makes clear that there are important differences between the way yeast and mammalian cells coordinate cell growth and size. These differences make sense biologically. Yeast is a single-celled organism - cells are independent of each other and can grow and divide as fast as the nutrients in their environment can support. Animal cells are part of a larger organism, so their growth affects the good of the whole animal, and it makes good biological sense that this is controlled by signals from other cells.

Understanding cell growth and proliferation is of profound importance for biology and has implications for tackling disease, including cancer.

Grace Baynes | BioMed Central Limited
Further information:
http://jbiol.com/content/2/1/7

More articles from Life Sciences:

nachricht Biophysicists reveal how optogenetic tool works
29.05.2020 | Moscow Institute of Physics and Technology

nachricht Mapping immune cells in brain tumors
29.05.2020 | University of Zurich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>